Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases

MOLECULAR INTERVENTIONS

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

1. NCCIH NIH HHS [R21 AT003633, AT-003633] Funding Source: Medline
2. NIAMS NIH HHS [R03 AR055741, AR-055741] Funding Source: Medline
3. NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003633] Funding Source: NIH RePORTER
4. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055741] Funding Source: NIH RePORTER